ALL THE NEWS

Gold Road receives Gruyere Scoping Study results

THE BOURSE WHISPERER: Gold Road Resources (ASX: GOR) has completed a Scoping Study into the development of the company’s Gruyere gold project in Western Australia. The Gruyere project comprises a large-scale open pit mine, a narrow vein underground mine at Central Bore and a conventional 5 million tonnes per annum (Mtpa) Carbon In Leach (CIL) […]

Sirius commences mining at Nova

THE BOURSE WHISPERER: Sirius Resources (ASX: SIR) has commenced development of the Nova nickel mine and construction of associated infrastructure. Sirius kicked off mining operations on the Australia Day public holiday having received final statutory approvals required for the commencement of operations on the mining lease. The milestone comes two and a half years since […]

Cardinal hits 51m gold intersection at Namdini

THE DRILL SERGEANT: Cardinal Resources (ASX: CDV) has encountered a further high-grade gold intersection at the Namdini Mining Licence, located within the company’s Bolgatanga project in Ghana. Cardinal recorded the 51 metres at 3.58 grams per tonne gold from 85m vertical intersection approximately 25m north along strike from a 43m gold intersection the company announced […]

Viralytics commences CAVATAK Bladder Cancer trial

THE ROADHOUSE PHARMACY: Viralytics Limited (ASX: VLA) has initiated a Phase 1 clinical trial of CAVATAK in patients with non-muscle invasive bladder cancer (NMIBC), also known as superficial bladder cancer. The trial, titled the CANON (CAVATAK in Non-muscle invasive bladder cancer) study, has enrolled the first of an expected 30 to 40 patients in a […]

Doray confirms Suzie mineralisation and extends Judy

THE DRILL SERGEANT: Doray Minerals (ASX: DRM) declared recent drilling carried out at the company’s Andy Well gold project in Western Australia has confirmed the potential for mine life extensions. Doray said shallow RC drilling at the Suzie Zone and, what it labelled, ‘opportune’ diamond drilling at the Judy Lode, both confirmed the continuance of […]

Prescient completes acquisition of AKTivate Therapeutics

THE ROADHOUSE PHARMACY: Prescient Therapeutics (ASX: VHL) has finalised the acquisition of specialty oncology company AKTivate Therapeutics and its novel cancer drug candidate triciribine phosphatemonohydrate (TCN-P). Prescient has paid US$300,000 cash consideration and issued 6.7 million shares to the vendors. The company will issue a further 5 million Prescient shares to the vendors contingent on […]

What the Analysts Say

WHAT THE ANALYSTS SAY: Interesting news and views from across the Resource Analyst universe. Website: www.beerandco.com.au Company: PLD Corporation (ASX: PLD) PLD has signed an agreement to acquire the Admiral Bay zinc deposit. Upon successful completion of due diligence, PLD will pay $0.5 million in cash, issue a $0.5 million convertible note, grant a 1.5 […]

AGM Season in Review

GUEST COMMENTATOR: Cannings Purple associate director Michael Vaughan provides his insights to the recent AGM season. As one season finishes, another begins. And as summer starts, December’s festivities close the door on another season – that of the AGM. We look at five takeaways from some of the annual shareholder meetings we attended this year. […]

Platypus Minerals

ONE OFF THE WOOD: Platypus Minerals managing director Tom Dukovcic  dropped into The Roadhouse to give us the lowdown on what’s happening at the company’s Peruvian projects.   Platypus Minerals has only been Platypus Minerals for 12 months since changing its name from Ashburton Minerals. Has there been any major change of focus since then […]

Friday Flashback

THE WEEKLY WRAP: The S&P 500 and Dow Jones ended last week on a positive note, recording their seventh straight week with gains. The Aussie market took heart from this and began our working week in fine fettle to open up with a smile, although the resources sector let Team Australia down again to be […]